中医临床研究
中醫臨床研究
중의림상연구
Clinical Journal of Chinese Medicine
2015年
30期
127-128
,共2页
晚期肺癌%益气养阴%中医疗法
晚期肺癌%益氣養陰%中醫療法
만기폐암%익기양음%중의요법
Advanced lung cancer%Yiqi Yangyin therapy%Traditional Chinese Medicine therapy
目的:分析观察中医益气养阴法对于肺癌的临床治疗效果.方法:研究对象为我院在2013年1月—2013年12月收治的50例晚期肺癌患者,随机分为对照组和观察组各25例.对照组采用化疗单一治疗,观察组在对照组基础上结合中医益气养阴疗法.治疗时长为42 d,治疗后对两组疗效进行对比分析.结果:在治疗有效性方面,观察组为56.0%,对照组为48.0%.不良反应方面,观察组数量明显低于对照组.结论:中医益气养阴疗法配合化疗可以有效的改善晚期肺癌化疗中的治疗效果,增强患者体质,提高患者生命质量.
目的:分析觀察中醫益氣養陰法對于肺癌的臨床治療效果.方法:研究對象為我院在2013年1月—2013年12月收治的50例晚期肺癌患者,隨機分為對照組和觀察組各25例.對照組採用化療單一治療,觀察組在對照組基礎上結閤中醫益氣養陰療法.治療時長為42 d,治療後對兩組療效進行對比分析.結果:在治療有效性方麵,觀察組為56.0%,對照組為48.0%.不良反應方麵,觀察組數量明顯低于對照組.結論:中醫益氣養陰療法配閤化療可以有效的改善晚期肺癌化療中的治療效果,增彊患者體質,提高患者生命質量.
목적:분석관찰중의익기양음법대우폐암적림상치료효과.방법:연구대상위아원재2013년1월—2013년12월수치적50례만기폐암환자,수궤분위대조조화관찰조각25례.대조조채용화료단일치료,관찰조재대조조기출상결합중의익기양음요법.치료시장위42 d,치료후대량조료효진행대비분석.결과:재치료유효성방면,관찰조위56.0%,대조조위48.0%.불량반응방면,관찰조수량명현저우대조조.결론:중의익기양음요법배합화료가이유효적개선만기폐암화료중적치료효과,증강환자체질,제고환자생명질량.
Objective: To analyze and observe the clinical curative effect the method of strengthening Qi and nourishing Yin on lung cancer.Methods: 50 advanced lung cancer patients admitted in our hospital between January,2013 to December,2013 were randomly divided into a control group and an observation group,25 cases in each group.The control group used the single chemotherapy treatment,while the observation group was trated with chemotherapy combined with the method of strengthening Qi and nourishing Yin in Traditional Chinese Medicine.The treatment period was 42d and after the treatment,the effects of the two groups were compared and analyzed.Results: In the aspect of the effectiveness,the observation group was 56.0%,control group 48.0%.and considering adverse reactions; the observation group was significantly lower than that of the control group.Conclusion: The method of strengthening Qi and nourishing Yin in Traditional Chinese Medicine combined with chemotherapy can effectively improve the effects in the treatment of advanced lung cancer,enhancing physical fitness and improving patient's quality of life.